CannBioRx Life Sciences Corp. (ATNFW) Financials

ATNFW Assets vs Liabilities

DateAssetsLiabilities
Sept. 30, 2023 5.0 million 5.1 million
June 30, 2023 13.7 million 7.0 million
March 31, 2023 14.9 million 7.8 million
Dec. 31, 2022 19.7 million 8.3 million

ATNFW Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2023 -1.8 million 583994
June 30, 2023 -3.1 million 551310
March 31, 2023 -3.9 million 557421
Dec. 31, 2022 -2.9 million 630846

ATNFW Net Income

No data available :(

ATNFW Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2023 2.7 million - -
June 30, 2023 2.0 million 26314 -
March 31, 2023 2.6 million - -
Dec. 31, 2022 7.0 million - -

ATNFW Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2023 8.0 million
June 30, 2023 5.2 million
March 31, 2023 3.7 million
Dec. 31, 2022 2.2 million

ATNFW Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2023 - 1.1 million 2.4 million -
June 30, 2023 - 920904 2.8 million -
March 31, 2023 - 794993 4.0 million -
Dec. 31, 2022 - 585690 5.1 million -

ATNFW Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2023 - 32693
June 30, 2023 - 28550
March 31, 2023 - 21772
Dec. 31, 2022 - 37608

ATNFW

Price: $0.43

52 week price:
0.01
0.46

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 101536

Market Capitalization: 73074

Links: